JBIO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$22.59

Capitalizzazione di Mercato

$761M

P/E (TTM)

-4.8

EPS (TTM)

$-3.19

Ricavi (TTM)

—

Rendimento div.

—

ROE

-47.7%

D/E Debito/Patrimonio

—

Intervallo 52 sett.

$7 – $28

JBIO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto —

EPS $-3.19

2021-12-31 → 2025-12-31

Flusso di cassa libero $-95M

2021-12-31 → 2025-12-31

Margini —

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

JBIO

Mediana dei peer

P/E (TTM)

-4.8

—

P/B

2.3

5.6

Price / FCF (Prezzo / FCF)

-8.0

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

JBIO

Mediana dei peer

ROA

-60.3%

-51.4%

ROE

-47.7%

-78.8%

ROIC

-34.2%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

JBIO

Mediana dei peer

Current Ratio (Rapporto corrente)

21.1

9.0

Quick Ratio

20.3

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

JBIO

Mediana dei peer

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

JBIO

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-3.19

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

JBIO

Mediana dei peer

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

Dividend Yield

—

Rapporto di Distribuzione Utili

—

CAGR Dividendi 5Y

—

Data ex-dividendo	Importo
29 Aprile 2025	$2,4000

JBIO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 16 analisti

Acquisto forte 8 50,0%
Compra 7 43,8%
Mantieni 1 6,2%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

7 analisti · 2026-05-15

Mediana $34.00

Ora $22.59

Basso $16.00

Alto $45.00

Target mediano $34.00 +50,5%

Target medio $32.86 +45,4%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

1.0%

Periodo	EPS Actual	EPS Stimato	Sorpresa
31 Marzo 2026	$-0.57	$-0.49	-0.08%
31 Dicembre 2025	$-0.59	$-0.48	-0.11%
30 Settembre 2025	$-0.48	$-0.69	0.21%
30 Giugno 2025	$-0.86	$-0.44	-0.42%
31 Marzo 2025	$-3.15	$-8.57	5.4%

Confronto tra pari Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
JBIO	$761M	-4.8	—	—	-47.7%	—
OLMA	$2.03B	-13.4	—	—	-39.4%	—
MPLT	$773M	-0.9	—	—	-151.1%	—
ZBIO	$1.98B	-4.3	100.0%	-3777.4%	-156.8%	—
PURR	—	—	—	—	—	—
CDNA	$959M	-47.1	13.8%	-5.6%	-6.8%	—
AKTS	—	—	—	—	—	—
CRVS	$575M	-14.5	—	—	-21.6%	—
SVRA	$1.23B	-11.4	—	—	-73.4%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 14

Dati annuali Conto Economico per JBIO
Metrica	2025	2024	2023	2022	2021	2020
R&D Expense	$93M	$53M	$64M	$39M	$15M	$8M
SG&A Expense	$20M	$21M	$17M	$15M	$8M	$949.0K
Operating Expenses	$114M	$75M	$81M	$53M	$23M	$9M
Operating Income	$-114M	$-75M	$-81M	$-53M	$-23M	$-9M
Interest Expense	·	·	·	·	·	$75.0K
Other Non-op	$-8.0K	$-19.0K	$-1.0K	$2M	$62.0K	$-722.0K
Pretax Income	$-127M	$-70M	$-75M	$-51M	$-23M	$-10M
Income Tax	$58.0K	$55.0K	$56.0K	$25.0K	$3.0K	·
Net Income	$-127M	$-70M	$-76M	$-52M	$-23M	$-10M
EPS (Basic)	$-3.19	$-2.44	$-2.87	$-2.10	$-1.87	·
EPS (Diluted)	$-3.19	$-2.44	$-2.87	$-2.10	$-1.87	·
Shares (Basic)	31,359,958	28,582,194	26,331,630	24,472,104	12,293,629	·
Shares (Diluted)	31,359,958	28,582,194	26,331,630	24,472,104	12,293,629	·
EBITDA	$-114M	$-75M	$-81M	$-53M	$-23M	·

Stato Patrimoniale 21

Dati annuali Stato Patrimoniale per JBIO
Metrica	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$88M	$69M	$23M	$22M	$54M	$5M
Short-term Investments	$248M	$0	$99M	$107M	$113M	·
Prepaid Expense	$13M	$268.0K	$2M	$2M	$7M	$103.0K
Current Assets	$349M	$70M	$124M	$131M	$174M	$5M
PP&E (Net)	$170.0K	·	$288.0K	$242.0K	$186.0K	$39.0K
PP&E (Gross)	·	·	·	·	·	$40.0K
Accum. Depreciation	·	·	·	·	·	$1.0K
Other Non-current Assets	$69.0K	$3M	$2M	$3M	$302.0K	·
Total Assets	$350M	$73M	$127M	$135M	$175M	$5M
Accounts Payable	$2M	$1M	$2M	$3M	$1M	$618.0K
Accrued Liabilities	$9M	$4M	·	·	·	·
Current Liabilities	$17M	$12M	$18M	$8M	$3M	$2M
Capital Leases	$724.0K	$0	$255.0K	$705.0K	$382.0K	·
Total Liabilities	$17M	$120M	$18M	$9M	$3M	$2M
Common Stock	$5.0K	$1.0K	$3.0K	$2.0K	$2.0K	·
Paid-in Capital	$507M	$179.0K	$273M	$215M	$209M	$63.0K
Retained Earnings	$-174M	$-47M	$-163M	$-88M	$-36M	$-13M
AOCI	$129.0K	$0	$237.0K	$-466.0K	$-59.0K	·
Stockholders' Equity	$333M	$-47M	$109M	$127M	$172M	$-13M
Liabilities + Equity	$350M	$73M	$127M	$135M	$175M	$5M
Shares Outstanding	49,316,287	3,672,794	27,762,703	24,722,974	24,410,393	243,076

Flusso di cassa 10

Dati annuali Flusso di cassa per JBIO
Metrica	2025	2024	2023	2022	2021	2020
Stock-based Comp	$20M	$11M	$12M	$5M	$2M	$58.0K
Deferred Tax	$-44.0K	·	·	·	·	·
Operating Cash Flow	$-95M	$-71M	$-57M	$-39M	$-27M	$-8M
CapEx	$196.0K	·	$142.0K	$195.0K	$181.0K	·
Investing Cash Flow	$-247M	$56M	$12M	$7M	$-113M	·
Stock Issued	·	$24M	$45M	·	$127M	·
Net Stock Activity	·	$24M	$45M	·	$127M	·
Financing Cash Flow	$361M	$25M	$46M	$396.0K	$190M	$9M
Net Change in Cash	$19M	$10M	$1M	$-32M	$50M	$1M
Free Cash Flow	$-95M	·	$-57M	$-39M	$-28M	·

Redditività 3

Dati annuali Redditività per JBIO
Metrica	2025	2024	2023	2022	2021	2020
ROA	-60.3%	-67.0%	-57.5%	-33.2%	-25.5%	·
ROE	-47.7%	-233.8%	-64.2%	-38.8%	-13.0%	·
ROIC	-34.2%	-97.7%	-74.4%	-42.0%	-13.4%	·

Liquidità e Solvibilità 2

Dati annuali Liquidità e Solvibilità per JBIO
Metrica	Tendenza	2025	2024	2023	2022	2021	2020
Current Ratio		21.1	20.9	7.0	16.9	68.4	·
Quick Ratio		20.3	20.5	6.9	16.6	65.6	·

Per Azione 4

Dati annuali Per Azione per JBIO
Metrica	2025	2024	2023	2022	2021	2020
Book Value / Share	$6.74	$2.64	$3.94	$5.13	$7.06	·
Cash Flow / Share	$-3.02	$-2.49	$-2.16	$-1.60	·	·
Cash / Share	$1.79	$1.16	$0.85	$0.91	$2.22	·
EPS (TTM)	$-3.19	$-2.44	$-2.87	$-2.10	$-1.87	·

Valutazione (TTM) 8

Dati annuali Valutazione (TTM) per JBIO
Metrica	2025	2024	2023	2022	2021	2020
Net Income TTM	$-127M	$-70M	$-76M	$-52M	$-23M	·
Market Cap	$761M	$2.69B	$21.99B	$25.35B	$10.07B	·
P/E	-4.8	-38.0	-276.0	-488.3	-220.7	·
P/B	2.3	35.2	200.9	200.0	58.4	·
P / Tangible Book	2.3	·	200.9	200.0	58.4	·
P / Cash Flow	-8.0	-37.8	-387.3	-648.1	-367.6	·
P / FCF	-8.0	·	-386.3	-644.8	-365.2	·
Earnings Yield	-20.7%	-2.6%	-0.36%	-0.20%	-0.45%	·

Conto Economico 13

Dati trimestrali Conto Economico per JBIO
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
R&D Expense	$36M	$29M	$22M	$23M	$20M	$-2M	$14M	$21M	$20M	$18M	$17M	$16M	$13M	$12M	$11M	$8M
SG&A Expense	$7M	$6M	$5M	$5M	$3M	$11M	$1M	$5M	$5M	$4M	$4M	$4M	$4M	$4M	$3M	$4M
Operating Expenses	$43M	$55M	$27M	$28M	$23M	$9M	$15M	$26M	$25M	$22M	$21M	$20M	$18M	$16M	$14M	$12M
Operating Income	$-43M	$-55M	$-27M	$-28M	$-23M	$-9M	$-15M	$-26M	$-25M	$-22M	$-21M	$-20M	$-18M	$-16M	$-14M	$-12M
Other Non-op	$-9.0K	$4M	$-28.0K	$-4M	$0	$-1M	$0	$1M	$-3.0K	$-2M	$1.0K	$1M	$1M	$2M	$4.0K	$-6.0K
Pretax Income	$-40M	·	·	·	$-38M	·	·	·	·	·	·	·	·	·	·	·
Income Tax	$16.0K	$58.0K	$0	$0	·	·	$0	·	·	·	·	·	·	·	·	·
Net Income	$-40M	$-32M	$-25M	$-32M	$-38M	$-5M	$-16M	$-25M	$-23M	$-20M	$-20M	$-19M	$-17M	$-15M	$-14M	$-12M
EPS (Basic)	$-0.57	$-1.76	$-0.48	$-0.86	$-12.10	$4.41	$-5.16	$-0.86	$-0.83	$-0.73	$-0.71	$-0.76	$-0.67	$-0.60	$-0.56	$-0.49
EPS (Diluted)	$-0.57	$-1.76	$-0.48	$-0.86	$-12.10	$4.41	$-5.16	$-0.86	$-0.83	$-0.73	$-0.71	$-0.76	$-0.67	$-0.60	$-0.56	$-0.49
Shares (Basic)	57,777,165	-65,640,708	39,584,489	28,431,158	3,155,500	-31,125,176	3,155,500	28,756,043	27,795,827	-51,253,264	27,640,542	25,166,505	24,777,847	-48,803,578	24,454,786	24,410,503
Shares (Diluted)	57,777,165	-65,640,708	39,584,489	28,431,158	3,155,500	-31,125,176	3,155,500	28,756,043	27,795,827	-51,253,264	27,640,542	25,166,505	24,777,847	-48,803,578	24,454,786	24,410,503
EBITDA	$-43M	·	$-27M	$-28M	$-3M	·	$-17M	$-26M	$-25M	·	$-21M	$-20M	$-18M	·	$-14M	$-12M

Stato Patrimoniale 19

Dati trimestrali Stato Patrimoniale per JBIO
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$55M	$88M	$50M	$221M	$44M	$34M	$31M	$31M	$9M	$23M	$32M	$61M	$27M	$22M	$22M	$27M
Short-term Investments	$256M	$248M	$149M	·	$32M	$45M	$58M	$73M	$90M	$99M	$103M	$89M	$92M	$107M	$120M	$125M
Prepaid Expense	$7M	$13M	$2M	$2M	$1M	$1M	$2M	$7M	$4M	$2M	$2M	$2M	$2M	$2M	$3M	$1M
Current Assets	$319M	$349M	$201M	$223M	$77M	$80M	$91M	$111M	$103M	$124M	$138M	$152M	$121M	$131M	$145M	$153M
PP&E (Net)	$157.0K	$170.0K	$176.0K	$147.0K	$2.0K	$6.0K	$14.0K	$232.0K	$260.0K	$288.0K	$316.0K	$245.0K	$267.0K	$242.0K	$330.0K	$316.0K
Other Non-current Assets	$69.0K	$69.0K	$174.0K	$60.0K	·	·	$81.0K	$81.0K	$3M	$2M	$2M	$2M	$3M	$3M	$1M	$731.0K
Total Assets	$319M	$350M	$202M	$224M	$78M	$80M	$91M	$112M	$107M	$127M	$141M	$156M	$124M	$135M	$148M	$156M
Accounts Payable	$4M	$2M	$1M	$8M	$69.0K	$224.0K	$908.0K	$4M	$3M	$2M	$4M	$6M	$5M	$3M	$5M	$2M
Accrued Liabilities	$15M	$9M	$14M	$8M	·	·	·	·	·	·	·	·	·	·	·	·
Current Liabilities	$22M	$17M	$22M	$22M	$2M	$4M	$10M	$17M	$16M	$18M	$15M	$13M	$11M	$8M	$8M	$4M
Capital Leases	$679.0K	$724.0K	$747.0K	$792.0K	·	·	$81.0K	$206.0K	$329.0K	$255.0K	$358.0K	$476.0K	$591.0K	$705.0K	$800.0K	$862.0K
Total Liabilities	$23M	$17M	$23M	$22M	$2M	$4M	$10M	$17M	$16M	$18M	$15M	$14M	$11M	$9M	$9M	$5M
Common Stock	$5.0K	$5.0K	$3.0K	$3.0K	$3.0K	$3.0K	$3.0K	$3.0K	$3.0K	$3.0K	$3.0K	$3.0K	$2.0K	$2.0K	$2.0K	$2.0K
Paid-in Capital	$512M	$507M	$322M	$319M	$311M	$309M	$308M	$306M	$278M	$273M	$269M	$266M	$218M	$215M	$213M	$211M
Retained Earnings	$-215M	$-174M	$-142M	$-117M	$-236M	$-233M	$-228M	$-211M	$-187M	$-163M	$-143M	$-123M	$-104M	$-88M	$-73M	$-59M
AOCI	$-342.0K	$129.0K	$29.0K	$-24.0K	$50.0K	$105.0K	$224.0K	$-83.0K	$-33.0K	$237.0K	$-195.0K	$-223.0K	$-201.0K	$-466.0K	$-771.0K	$-785.0K
Stockholders' Equity	$296M	$333M	$179M	$202M	$75M	$76M	$80M	$94M	$91M	$109M	$126M	$142M	$113M	$127M	$139M	$151M
Liabilities + Equity	$319M	$350M	$202M	$224M	$78M	$80M	$91M	$112M	$107M	$127M	$141M	$156M	$124M	$135M	$148M	$156M
Shares Outstanding	49,345,967	49,316,287	32,626,730	32,626,730	28,985,019	28,985,019	28,867,711	28,854,750	27,898,761	27,762,703	27,653,187	27,601,098	24,816,940	24,722,974	24,506,390	24,418,434

Flusso di cassa 8

Dati trimestrali Flusso di cassa per JBIO
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Stock-based Comp	$7M	$11M	$4M	$4M	$2M	$3M	$27.0K	$4M	$4M	$3M	$3M	$3M	$2M	$2M	$1M	$1M
Operating Cash Flow	$-24M	$-34M	$-22M	$-37M	$-19M	$-11M	$-7M	$-20M	$-24M	$-15M	$-16M	$-15M	$-11M	$-15M	$-10M	$-9M
CapEx	·	$3.0K	$57.0K	·	·	·	·	·	·	$64.0K	$32.0K	$30.0K	$16.0K	$4.0K	$33.0K	$130.0K
Investing Cash Flow	$-8M	$-98M	$-149M	$-13M	$13M	$13M	$0	$18M	$9M	$6M	$-13M	$4M	$15M	$14M	$5M	$8M
Stock Issued	·	·	·	·	·	$307.0K	$0	·	·	$0	$0	·	·	·	·	·
Financing Cash Flow	$-795.0K	$170M	$0	$191M	$-700.0K	$554.0K	$95M	$24M	$471.0K	$463.0K	$20.0K	$45M	$223.0K	$357.0K	$37.0K	·
Net Change in Cash	$-33M	$38M	$-171M	$141M	$-19M	$3M	$88M	$22M	$-14M	$-9M	$-29M	$34M	$4M	$-22.0K	$-5M	$-680.0K
Free Cash Flow	·	·	·	·	·	·	·	·	·	·	·	·	$-11M	·	·	·

Redditività 3

Dati trimestrali Redditività per JBIO
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
ROA	-20.3%	·	-17.2%	-19.1%	-2.7%	·	-14.0%	-18.5%	-20.1%	·	-13.6%	-12.2%	-11.3%	·	-8.2%	-11.0%
ROE	-21.7%	·	-19.4%	-21.7%	-3.0%	·	-15.8%	-21.0%	-22.7%	·	-14.8%	-13.0%	-12.0%	·	-8.5%	-18.5%
ROIC	-14.7%	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·

Liquidità e Solvibilità 2

Dati trimestrali Liquidità e Solvibilità per JBIO
Metrica	Tendenza	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio		14.3	·	9.0	10.3	32.0	·	8.8	6.5	6.7	·	9.3	11.5	11.3	·	18.8	40.9
Quick Ratio		14.0	·	8.9	10.2	31.5	·	8.6	6.1	6.4	·	9.2	11.3	11.2	·	18.5	40.5

Per Azione 4

Dati trimestrali Per Azione per JBIO
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$6.01	·	$5.50	$6.18	$2.59	·	$2.79	$3.27	$3.26	·	$4.55	$5.14	$4.56	·	$5.68	$6.19
Cash Flow / Share	$-0.42	·	·	·	$-0.08	·	·	·	$-0.85	·	·	·	$-0.46	·	·	·
Cash / Share	$1.12	·	$1.54	$6.77	$1.53	·	$1.08	$1.08	$0.33	·	$1.16	$2.21	$1.07	·	$0.91	$1.12
EPS (TTM)	$-14.01	·	$-6.59	$-6.97	$-6.94	·	$-7.56	$-3.16	$-2.97	·	$-2.70	$-2.48	$-2.17	·	$-1.76	·

Valutazione (TTM) 8

Dati trimestrali Valutazione (TTM) per JBIO
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Net Income TTM	$-136M	·	$-112M	$-111M	$-102M	·	$-84M	$-87M	$-78M	·	$-69M	$-61M	$-53M	·	$-43M	$-35M
Market Cap	$693M	·	$282M	$326M	$2.55B	·	$2.11B	$1.68B	$28.87B	·	$13.13B	$16.57B	$17.52B	·	$14.22B	$13.36B
P/E	-1.0	·	-1.3	-1.4	-12.7	·	-9.7	-18.4	-348.5	·	-175.9	-242.0	-325.3	·	-329.7	·
P/B	2.3	·	1.6	1.6	33.9	·	26.2	17.8	317.6	·	104.5	116.7	154.9	·	102.2	88.4
P / Tangible Book	2.3	·	1.6	1.6	33.9	·	26.2	17.8	317.6	·	104.5	116.7	154.9	·	102.2	88.4
P / Cash Flow	-28.8	·	·	·	-1069.4	·	·	·	-1219.7	·	·	·	-1533.6	·	·	·
P / FCF	·	·	·	·	·	·	·	·	·	·	·	·	-1531.4	·	·	·
Earnings Yield	-99.7%	·	-76.4%	-69.8%	-7.9%	·	-10.3%	-5.4%	-0.29%	·	-0.57%	-0.41%	-0.31%	·	-0.30%	·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Utile netto	$-127M	$-70M	$-76M	$-52M	$-23M
EPS Diluito	$-3.19	$-2.44	$-2.87	$-2.10	$-1.87

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	21.1	20.9	7.0	16.9	68.4
Quick Ratio	20.3	20.5	6.9	16.6	65.6

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-95M	—	$-57M	$-39M	$-28M

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

JBIO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

JBIO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

JBIO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto tra pari Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi